BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/19/2024 12:40:27 PM | Browse: 136 | Download: 551
 |
Received |
|
2024-01-06 00:46 |
|
Peer-Review Started |
|
2024-01-06 00:46 |
|
First Decision by Editorial Office Director |
|
2024-04-08 06:59 |
|
Return for Revision |
|
2024-04-08 06:59 |
|
Revised |
|
2024-05-05 20:08 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-05-23 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-05-23 06:19 |
|
Articles in Press |
|
2024-05-23 06:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-07 01:44 |
|
Publish the Manuscript Online |
|
2024-06-19 12:40 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Review |
| Article Title |
Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of de novo lipogenesis and therapeutic consideration
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohammad M Khan, Zaw Ali Khan and Mohsin Ali Khan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohammad M Khan, PhD, Professor, Laboratory of Translational Neurology and Molecular Psychiatry, Department of Biotechnology, Era’s Lucknow Medical College and Hospital, Faculty of Science, Era University, Sarfarazganj, Hardoi Road, Lucknow 226003, India. mmkhan0@gmail.com |
| Key Words |
Psychotropic medications; Metabolic complications; De novo lipogenesis; Obesity; Diabetes; Non-alcoholic fatty liver disease |
| Core Tip |
Psychotropic medications are the first line of treatment for psychiatric disorders; however, their long-term use has been shown to induce various metabolic abnormalities including diabetes, obesity, and fatty liver disease. Although mechanism(s) underlying these metabolic abnormalities is not clear, lipid/fatty acid accumulation caused by enhanced de novo lipogenesis (DNL) could be the primary mediator. In this regard, various anti-inflammatory drugs that are used in combination therapy, have been shown to reduce DNL and the aforementioned metabolic abnormalities in laboratory animals. This suggests that DNL could be a potential pathological and therapeutic target, and a new avenue for translational research in psychiatric disorders. |
| Publish Date |
2024-06-19 12:40 |
| Citation |
Khan MM, Khan ZA, Khan MA. Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of de novo lipogenesis and therapeutic consideration. World J Psychiatry 2024; 14(6): 767-783
|
| URL |
https://www.wjgnet.com/2220-3206/full/v14/i6/767.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v14.i6.767 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
